| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/01/2007 | CA2615777A1 Tfpi fragments as anti-microbial agents |
| 02/01/2007 | CA2614532A1 Method for induction and enhancement of apoptosis in tumor cells |
| 02/01/2007 | CA2612937A1 Concentrated protein lyophilates, methods, and uses |
| 02/01/2007 | CA2612597A1 Airway administration of activated protein c in inflammatory conditions affecting the respiratory tract |
| 01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1748065A2 Cell cycle progression proteins |
| 01/31/2007 | EP1748050A1 Targeting-enhanced activation of galectins |
| 01/31/2007 | EP1747284A2 Diagnosis and therapeutics for cancer |
| 01/31/2007 | EP1747270A2 Synthetic fluorouridine-activating enzyme for cancer therapy |
| 01/31/2007 | EP1747234A1 A protein involved in cancer |
| 01/31/2007 | EP1747227A2 Combinatorial selection of phosphorothioate aptamers for tgf-beta |
| 01/31/2007 | EP1747226A1 Pharmaceuticals for enhanced deliver to disease targets |
| 01/31/2007 | EP1747014A2 Modulation of lysophosphatidylcholine and treatment of diet-induced conditions |
| 01/31/2007 | EP1747011A2 Means and method for diagnosis, prophylaxis and therapy of connective tissue diseases |
| 01/31/2007 | EP1747010A1 Use of sulglicotide for the treatment of mucositis |
| 01/31/2007 | EP1747009A1 Use of histones for the early diagnosis and/or preventive therapy of virus-infected living cells and a biochip for carrying out said diagnosis |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | EP0978560B1 Process for producing l-methionine gamma-lyase crystals |
| 01/31/2007 | EP0804574B1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/31/2007 | CN1906302A Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 01/31/2007 | CN1906299A Immunization against chlamydia infection |
| 01/31/2007 | CN1906297A IL-23 and its receptor, related reagents and methods |
| 01/31/2007 | CN1906296A Methods for the production of apolipoproteins in transgenic plants |
| 01/31/2007 | CN1906213A Interleukin-10 antibodies |
| 01/31/2007 | CN1906211A Novel muscle growth regulator |
| 01/31/2007 | CN1906209A Stabilized alpha helical peptides and uses thereof |
| 01/31/2007 | CN1906208A Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 01/31/2007 | CN1906205A Reduction of dermal scarring |
| 01/31/2007 | CN1905921A Local intraosseous administration of bone forming agents and anti-resorptive agents and devices therefor |
| 01/31/2007 | CN1905897A Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 01/31/2007 | CN1905895A Biomarkers for the efficacy of somatostatin analogue treatment |
| 01/31/2007 | CN1905894A Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment |
| 01/31/2007 | CN1905893A Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/31/2007 | CN1905892A Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/31/2007 | CN1905890A Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 01/31/2007 | CN1905867A Facially amphilic polymers and oligomers and uses thereof |
| 01/31/2007 | CN1904041A Human recombination phospholipase D2, its preparation method and application in preparation medicine |
| 01/31/2007 | CN1904036A Method of producing three kinds of human alpha alexins by gene engineering bacteria mixed culture |
| 01/31/2007 | CN1903881A Antitumour multitarget composite antigen, its coding gene and application |
| 01/31/2007 | CN1903877A Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
| 01/31/2007 | CN1903876A Polypeptide, nucleic acid molecule coding it and use |
| 01/31/2007 | CN1903362A Traditional Chinese medicine for hepatitis A or B patient to transfer positive to negative |
| 01/31/2007 | CN1903361A Application recombinant streptokinase for preparing medicine to treat high viscosity blood disease |
| 01/31/2007 | CN1903360A Calcium-tablet for preventing osteoporosis |
| 01/31/2007 | CN1903359A Application of musculus growth inhibin for preparing anticarcinogen |
| 01/31/2007 | CN1903358A Compound bone peptide medicine composition oral prepn. and prepn. method therefor |
| 01/31/2007 | CN1903357A Liver hydrolytic peptide for injection and prepn. method therefor |
| 01/31/2007 | CN1903179A Preparing method of powder agglomerates |
| 01/31/2007 | CN1903172A Poloxamer thymic peptide alpha 1 long-acting temp.-sensing gel |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297281C Method for treatment of leukaemia |
| 01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| 01/30/2007 | US7169906 Nucleotide sequences coding polypeptide for use in the treatment of skin and nervous system disorders |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 01/30/2007 | US7169898 Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 01/30/2007 | US7169897 Adipocyte complement related protein ZACRP3X2 |
| 01/30/2007 | US7169896 Producing partially modified and partially hydrolysed fiberous protein; isolate feather, solubilize, incubate with reducing agent, recover protein; isolating fiberous protein from waste feathers for use in textile processing and supplementing cosmetics |
| 01/30/2007 | US7169893 Human HAC3 |
| 01/30/2007 | US7169892 Wherein the lipid is conjugated to the amino terminus of the peptide by a peptide bond and the water-soluble polymer is conjugated to the carboxy terminus of the peptide by a peptide bond; for use as colloidal carriers and the like of tissue-specific drug delivery systems |
| 01/30/2007 | US7169890 New amide derivatives of deacylated ramoplanin have the same or better antinfective activity, lower hemolytic effect and better tolerability profile than ramoplanin |
| 01/30/2007 | US7169889 Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
| 01/30/2007 | US7169888 For inhibiting angiogenesis in a mammal; cancer therapy |
| 01/30/2007 | US7169806 Antidiabetic agents |
| 01/30/2007 | US7169805 Captopril derivatives |
| 01/30/2007 | US7169783 For regulation of growth of neurons in the Central Nervous System |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169767 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | US7169759 Tetrapeptide inhibitors of β-secretase |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169757 Administering therapeutically effective amount of composition comprising caseino-glycomacropeptide, an agent that chemically blocks functional groups in caseino-glycomacropeptide and a hydrophobic resin; for treatment of caries, plaque formation, dental diseases, diseases of mouth; reduced off-flavor |
| 01/30/2007 | US7169756 Cyclic peptide antibiotic wherein antibiotic is a streptogramin Type B derivative and is characterized by the replacement of an enzyme sensitive ester bond with a stable bond selected from an amide, N-methyl amide, enamine and sulfonamide bond |
| 01/30/2007 | US7169755 Viscosity-enhancing agent to increase the residence time of the solution in the heating chamber thereby increasing the expulsion force of the solution from the handpiece |
| 01/30/2007 | US7169754 Blood disorders; drug in aqueous solution |
| 01/30/2007 | US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification |
| 01/30/2007 | US7169752 Covalently bonding at 6' position and 14' position of oxycodone a single amino acid or oligopeptide of 12 or fewer amino acids; when delivered at proper dosage composition provides therapeutic activity similar to that of parent active agent; when delivered at higher dose potential for overdose is reduced |
| 01/30/2007 | US7169751 combining a compound to be tested with a 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 polypeptide for binding of the test compound to the polypeptide; detecting binding for pain treatment |
| 01/30/2007 | US7169750 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 01/30/2007 | US7169605 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169581 IL-18 receptors |
| 01/30/2007 | US7169580 Protein having PGE2 synthase activity and use thereof |
| 01/30/2007 | US7169574 Fluorescence detection of proteases or peptidases |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | US7169566 Metalloproteinases |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169408 Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections |
| 01/30/2007 | US7169406 Drug delivery; analgesics, antiinflammatory agents; contacting skin with hydrogel containing drugs |
| 01/30/2007 | US7169405 chemonucleolysis agent in solid form such that, when the device is placed into the nucleus pulposus of the intervertebral disc, it releases the chemonucleoylysis agent into the nuclear disc tissue surrounding the device to proteolytically degrade the tissue |
| 01/30/2007 | US7169395 combining a mixture of RSV proteins with non-virulent influenza virus in a vaccine formulation provides an immune response which is substantially the same as the response obtained by administration of the components individually |
| 01/30/2007 | US7169390 Administering an agent binds a sphingolipid or a sphingolipid metabolite, especially an antibody or derivative, a receptor of a sphingolipid or a sphingolipid metabolite. |
| 01/30/2007 | US7169388 unexpected discovery that the inhibition or antagonism of TNF decreases the expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF). VEGF has been implicated in the angiogenesis in cancer, vascular diseases and rheumatoid arthritis |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169386 Chimeric immunoglobulin; for the diagnosis and treatment of bacterail infection, cancer and septic shock |
| 01/30/2007 | US7169385 Solubilized CoQ-10 and carnitine |